Close Menu
Home » FDA Issues Emergency Use Authorization for CDC Novel Coronavirus Test

FDA Issues Emergency Use Authorization for CDC Novel Coronavirus Test

Feb 04, 2020
|
staff reporter

This story has been updated to include comments from a media briefing on Wednesday.

NEW YORK – The US Food and Drug Administration late on Tuesday issued an emergency use authorization for a test from the US Centers for Disease Control and Prevention for the novel coronavirus, 2019-nCoV.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cost of a Visa

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Rethinking Access Order

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

May Have to Close

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

Nature Papers Present Way to Analyze Cancer Mutational Signatures, Explore Treatment Resistance in Lung Cancer, More

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Novacyt Gets CE Mark for Coronavirus Test

  2. FDA Releases List of Evidence-Based PGx Variants

  3. Lucid Diagnostics EsoGuard DNA Test Gets FDA Breakthrough Device Status

  4. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.